How Africa Can Meet Its Daunting Production Challenge For Critical Disease Vaccines
Executive Summary
Africa is taking steps to massively increase its vaccine production capacity and reduce its heavy dependence on other countries for supplies. Muthoni Wanyeki of the Open Society Foundations explained to the Pink Sheet how COVID-19 has highlighted the need for action and why it is important to keep up the momentum achieved so far.
You may also be interested in...
Boost For South African Agency’s Regulatory Oversight Of Vaccine Manufacturing
The donation of equipment to SAHPRA may be a small step in the greater scheme of things, but every little helps when it comes to building up Africa’s self-sufficiency in vaccine production.
WHO Steps Up Drive To Build Local Drug & Vaccine Production In Lower-Income Countries
The COVID-19 pandemic has underlined the need for less well-resourced countries to improve access to medicines, vaccines, medical devices and other health products by building their own production capacities.
All Eyes On Rwanda As Africa Builds Up Regulatory & Manufacturing Abilities
The small central African country has been chosen to host the planned African Medicines Agency and is also set to be a key player in medicines and vaccines manufacturing technology on the continent.